SCHEMBL20766130

SCHEMBL20766130

NC1CCn2cncc2C1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 12/20 0.32
▸ CYP11B1 P15538 3/20 0.32
▸ CYP11B2 P19099 3/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ SSTR2 P30874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24424530 0.77 NCF1 (0.34) CYP19A1CYP11B1CYP11B2KCNH2
SCHEMBL23623038 0.73 IDO1 (0.33) CYP19A1CYP11B1CYP11B2KCNH2
SCHEMBL24928597 0.73 CYP19A1 (0.35) CYP19A1CYP11B1CYP11B2KCNH2
SCHEMBL20225483 0.69 MAPT (0.32) —
SCHEMBL18365858 0.68 SSTR2 (0.31) SSTR2
Hydrochloric Acid SCHEMBL25303729 0.67 CYP17A1 (0.37) —
SCHEMBL2355428 0.66 CYP19A1 (0.54) CYP19A1CYP11B1CYP11B2KCNH2
SCHEMBL24424515 0.66 ADH1B (0.38) —
SCHEMBL24035779 0.65 DRD2 (0.50) —
SCHEMBL3933129 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040106-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 — — WO disclosed
Send feedback